Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark

[1]  A. Rudich,et al.  Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men , 2007, Annals of Internal Medicine.

[2]  Robert A Rizza,et al.  Progression From Newly Acquired Impaired Fasting Glucose to Type 2 Diabetes , 2007, Diabetes Care.

[3]  A. Dobson,et al.  Short-Term Weight Change and the Incidence of Diabetes in Midlife , 2007, Diabetes Care.

[4]  N. Wareham,et al.  Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: The Ely study 1990–2000 , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[5]  K. Borch-Johnsen,et al.  Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark , 2007, Diabetologia.

[6]  S. Yusuf,et al.  The DREAM trial – Authors' reply , 2006, The Lancet.

[7]  David W. Dunstan,et al.  Beneficial Associations of Physical Activity With 2-h but Not Fasting Blood Glucose in Australian Adults , 2006, Diabetes Care.

[8]  M. Laakso,et al.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.

[9]  R. DeFronzo,et al.  Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance Results From the Veterans Administration Genetic Epidemiology Study , 2006 .

[10]  C. Snehalatha,et al.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) , 2006, Diabetologia.

[11]  S. Fowler,et al.  Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. , 2005, Diabetes.

[12]  K. Kosaka,et al.  Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. , 2005, Diabetes research and clinical practice.

[13]  Hideo Ayame,et al.  [The Da Qing IGT and Diabetes study]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[14]  K. Borch-Johnsen,et al.  Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms , 2004, Diabetologia.

[15]  J. Shaw,et al.  High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius , 2004, Journal of internal medicine.

[16]  T. Valle,et al.  Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. , 2004, Archives of internal medicine.

[17]  Bendix Carstensen,et al.  A Danish diabetes risk score for targeted screening: the Inter99 study. , 2004, Diabetes care.

[18]  L. Bouter,et al.  Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: The Hoorn Study , 1996, Diabetologia.

[19]  W. Knowler,et al.  Glycated haemoglobin predicts progression to diabetes mellitus in Pima Indians with impaired glucose tolerance , 1994, Diabetologia.

[20]  T. Valle,et al.  Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[21]  Chien-Jen Chen,et al.  Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years. , 2003, Diabetes research and clinical practice.

[22]  J. Meigs,et al.  The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. , 2003, Diabetes.

[23]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[24]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[25]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[26]  J M Dekker,et al.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. , 2001, JAMA.

[27]  S. Keinänen-Kiukaanniemi,et al.  Antihypertensive drugs as predictors of type 2 diabetes among subjects with impaired glucose tolerance. , 2000, Diabetes research and clinical practice.

[28]  T Lauritzen,et al.  The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening , 2000, International Journal of Obesity.

[29]  S. Wannamethee,et al.  Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. , 1999, Diabetes care.

[30]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[31]  R. Bain,et al.  Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies , 1997, Diabetes.

[32]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[33]  B. Carstensen.  Regression models for interval censored survival data: application to HIV infection in Danish homosexual men. , 1996, Statistics in medicine.

[34]  C. Farrington.  Interval censored survival data: a generalized linear modelling approach. , 1996, Statistics in medicine.

[35]  L. Lissner,et al.  Diabetes incidence in users and non‐users of antihypertensive drugs in relation to serum insulin, glucose tolerance and degree of adiposity: a 12‐year prospective population study of women in Gothenburg, Sweden , 1992, Journal of internal medicine.

[36]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[37]  Dang Qing,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The , 2022 .